Carstar Car - t

Tarihin ci gaba na mota - T Cely Terrapy

Za'a iya gano motocin CARE zuwa 1989, lokacin da aka gicciye G da wasu wasu masana kimiyyar ukun da suka fara ba da shawarar manufar "mota". Bayan haka, a cikin 2008, Cutarwar ta fred Hutchison ta fara amfani da sel na mota T don yi da B - Lymhoma na B - ta nuna amincin wannan hanyar warkewa. A shekara ta 2010, yanayin nasarar farko na CD19 - Mota mai niyya - T Farfea na B - Cell - Tergkin Lymphoma aka ruwaito a Amurka. Sannan a shekara ta 2011, Farfesa Carl Yuni na Jami'ar Pennsylvania ta ci gaba, da kuma nasarar nasarar tantaninta na Emily ta shiga sabon lokacin fashewa. A cikin 2017, abincin da ake ci gaba da magani na Amurka (FDA) ya amince da izinin tallan kayan aikin Kymriah, wanda ke nuna alamar sel na kasuwanci na farko. A wannan shekarar, Jemunta, motar ta biyu - ta kuma amince da takardar izinin tallatawa. A shekarar 2020, FDA ta amince da mota ta uku t - Samfurin samfurin warkarwa na Tecarus. In 2021, the FDA approved two CAR-T immunotherapy products, Breyanzi and Abecma, for the treatment of refractory or relapsing large B-cell lymphoma and multiple myeloma, respectively. A wannan shekarar, CDE daga China kuma sun amince da izinin tallata takalmin kayan kwalliya biyu tare da jingina ko maimaitawa ko maimaitawa.

A cikin 2022, FDA ta amince da izinin tallan hanyar Carvykti, mota - Talwar samfurin samfurin maltimar ta boldoma ko sake jingina na myeloma.

A wannan gaba, ƙwayar ƙwayar car ta shigar da amai ta cutar hana cutar hana cutar ta hana haihuwa kuma ta buɗe wani kwazazzabo a duniya.

Mene ne mota - T Cely Terrapy

MAR T Cely Terfapy. Hakanan ana kiranta Chimeric Antigen Repigor Tellimonothera (MOAR - T), cuta ce ta ƙwayar cuta ta canza sel a cikin cento. Wannan yana ba su damar fahimtar ainihin ƙwayoyin tumatir da kuma basussukan sel baya cikin haƙuri don cutar da cutar.

Iit sa A cikin sa Aji na asibiti Sahi sana'ar kasuwanci

Mota - t